SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

CAC 40 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

Sanofi-Aventis: Click to view the issuer\'s details

Last update : 29/03/2019  >View issuer details

2019.06.09 | 19:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Soliqua® Phase 3 results significantly lowered blood sugar levels compared to GLP-1 receptor agonist treatments - HTML (w)

2019.06.07 | 07:00 | Permanent Information Releases / Appointments

English version HTML (w) Mail

puce Paul Hudson to succeed Olivier Brandicourt as Chief Executive Officer - HTML (w)

2019.06.07 | 07:00 | Permanent Information Releases / Appointments

French version HTML (w) Mail

puce Paul Hudson succèdera à Olivier Brandicourt comme Directeur Général - HTML (w)

2019.05.21 | 20:23 | Share History / Voting Rights and Number of Shares

English version HTML (w) Mail

puce Information concerning the total number of voting rights and shares - HTML (w)

2019.05.21 | 20:23 | Share History / Voting Rights and Number of Shares

French version HTML (w) Mail

puce Informations relatives au nombre total de droits de vote et d'actions - HTML (w)

2019.05.07 | 15:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Sanofi : Dupixent® (dupilumab) Approved for Severe Asthma by European Commission - HTML (w)

2019.05.07 | 15:00 | Permanent Information Releases / General Company News

French version HTML (w) Mail

puce Sanofi : Dupixent® (dupilumab) approuvé dans le traitement de l'asthme sévère par la Commission européenne - HTML (w)

2019.04.30 | 18:00 | Annual General Meeting / AGM

English version HTML (w) Mail

puce Sanofi: Annual General Meeting of April 30, 2019 - HTML (w)

2019.04.30 | 18:00 | Annual General Meeting / AGM

French version HTML (w) Mail

puce Sanofi : Assemblée Générale Annuelle du 30 avril 2019 - HTML (w)

2019.04.26 | 22:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce ZynquistaTM now approved in the European Union for treatment of adults with type 1 diabetes - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 2680